Benefit of tianeptine and morphine in a transgenic model of familial amyotrophic lateral sclerosis (Q58282308)

https://api.crossref.org/works/10.1080%2F14660820510012022

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

Effects of tianeptine on 5-hydroxyindoles and on the morphine-induced increase in 5-HT metabolism at the medullary dorsal horn level as measured by in vivo voltammetry in freely moving rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

Tianeptine stimulates uptake of 5-hydroxytryptamine in vivo in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

Effects of the antidepressant drug tianeptine on plasma and platelet serotonin concentrations in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

Increased serotonin platelet uptake after tianeptine administration in depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

Mechanisms of selective motor neuron death in ALS: insights from transgenic mouse models of motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

Beneficial effects of lysine acetylsalicylate, a soluble salt of aspirin, on motor performance in a transgenic model of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

Neuroprotective effects of riluzole on N-methyl-D-aspartate- or veratridine-induced neurotoxicity in rat hippocampal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

Organization of descending serotonergic projections to the spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

Autoradiographic mapping of 5-HT1, 5-HT1A, 5-HT1B and 5-HT2 receptors in the rat spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

Effect of repeated treatment with tianeptine and fluoxetine on central dopamine D(2) /D(3) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ opioid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

Transgenic superoxide dismutase mice differ in opioid-induced analgesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

A comparison of morphine-induced locomotor activity and mesolimbic dopamine release in C57BL6, 129Sv and DBA2 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

Inhibition of diazepam on morphine-induced hyperactivity, reverse tolerance and postsynaptic dopamine receptor supersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

Influence of acute or repeated restraint stress on morphine-induced locomotion: involvement of dopamine, opioid and glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

The involvement of noradrenergic transmission in the morphine-induced locomotor hyperactivity in mice withdrawn from repeated morphine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022

Pharmacokinetic differences of morphine and morphine-glucuronides are reflected in locomotor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14660820510012022